Monthly cadence
Structured stock research. Bear case first.
Versioned, archetype-calibrated reports built for a monthly research cycle. Fair value is a range, confidence is explicit, and there is no issuer-paid rating product.
Five testable promises
Fair value as a range, with a confidence number
Every report publishes a fair-value low / mid / high band rather than a single point estimate, paired with a 0 to 100 confidence score that reflects model agreement and data quality. A wide range with low confidence is information; a single number masquerading as truth is not.Bear case before bull case
The risk section runs first, in full, with named kill scenarios and quantified downside targets. Optimistic narrative is allowed only after the thesis has been argued against on its own terms. This ordering is structural, not editorial.Archetype-aware models
A hyper-growth software business and a deep cyclical commodity producer should not be valued the same way. Each analyzed ticker is assigned a named archetype, and that classification calibrates discount rates, terminal growth, deceleration curves, terminal multiples, and which valuation models apply.A scorecard with explicit weights
Every report carries a quantified investment scorecard whose category weights are published, not hidden. Disagreeing with the verdict is fine; disagreeing without seeing the math is what most retail research forces you into.Quantified stress tests, every report
Five named stress scenarios with dollar-impact estimates run on every covered ticker. Sensitivity grids on cost of equity and terminal growth ship in every report so the durability of the fair-value range is explicit, not implied.
What this is not
Not a signal service, not a copy-trading app, not a paywalled-newsletter cult of personality, not a screener with prose laid on top. The output is a reasoned investment thesis you can argue with, not a trade you are told to make.
Frequently asked
On independence
- The product uses a versioned, archetype-aware methodology and publishes assumptions, fair-value ranges, and confidence. The current featured research is free; subscriptions govern archive depth, saved tools, export, and developer capabilities according to the plan manifest.
- The product catalog has no issuer-paid rating, sponsored-placement, or conclusion pre-clearance offering. The methodology is automated and versioned. We do not claim a verified employee personal-trading control until an auditable policy and operating evidence exist; see the editorial guidelines for the exact current contract.
- Fair value is a probability-weighted composite reconciled across multiple valuation lenses, with explicit confidence and a published range. It is an estimate, not a promise. The reader should use the sensitivity tables, assumptions, and dated inputs to judge how fragile the range is.
- No. We publish educational research. We are not a broker-dealer, registered investment adviser, or fiduciary. Nothing on this site is personalized investment advice. See the Terms of Service for full regulatory framing.
Compared with
How this lens compares to the incumbents
- We compare research workflows without naming third-party platforms.